Article

Advancements in Field of Multiple Sclerosis

Author(s):

HealthIne

Joan Ohayon, registered nurse practitioner, discusses the advancements of research and treatment options in MS.

Joan Ohayon, registered nurse practitioner, National Institute of Neurological Disorders and Stroke, discusses the advancements of treating multiple sclerosis and clinical trials evaluating new treatments. Ohayon said that after the first approved MS treatment in 1993, there have been FDA six medications approved by the FDA.

Source:

Healthline

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Related Content
Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision | HCPLive.com
December 21st 2024

Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision

Isabella Ciccone, MPH
Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024
October 27th 2024

Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
System Integration: How AI Is Weaving Itself into Neurology
December 5th 2024

System Integration: How AI Is Weaving Itself into Neurology

Marco Meglio
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
April 17th 2024

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Oussama Wazni, MD | Credit: HCPLive
November 17th 2024

Oussama Wazni, MD, MBA: OPTION Trial and the Role of LAAC in Atrial Fibrillation

Oussama Wazni, MD Patrick Campbell
Ellen Sher, MD | Credit: Allergy Partners
November 11th 2024

Ellen Sher, MD: Cross-Specialty Collaboration Can Improve Atopic Dermatitis Management

Ellen Sher, MD Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.